Open-Label CDCA 250 mg TID

( DrugBank: - / KEGG DRUG: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
263	Cerebrotendinous xanthomatosis	1

263. Cerebrotendinous xanthomatosis

Clinical trials : 6 / Drugs : 11 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 4

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04270682 (ClinicalTrials.gov)	January 31, 2020	12/2/2020	Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)	A Phase 3 Study to Evaluate the Effects of Chenodeoxycholic Acid in Adult and Pediatric Patients Wit ...	CTX	Drug: Blinded CDCA 250 mg TID;Drug: Placebo;Drug: Open-Label CDCA 250 mg TID;Drug: Rescue Medication ...	Travere Therapeutics, Inc.	NULL	Recruiting	1 Month	N/A	All	12	Phase 3	United States;Brazil

First Previous1Next Last